BlackRock Enhanced Government Fund (EGF) Is At $13.46 Formed Wedge; Repros Therapeutics (RPRX) Has 0.22 Sentiment

November 15, 2017 - By Clifton Ray

BlackRock Enhanced Government Fund Inc (EGF) formed wedge up with $14.13 target or 5.00% above today’s $13.46 share price. BlackRock Enhanced Government Fund Inc (EGF) has $87.42M valuation. The stock decreased 0.14% or $0.02 on November 14, reaching $13.46. About shares traded. BlackRock Enhanced Government Fund Inc (NYSE:EGF) has declined 1.48% since November 15, 2016 and is downtrending. It has underperformed by 18.18% the S&P500.

Repros Therapeutics, Inc. is a biopharmaceutical firm focused on the development of new drugs to treat hormonal and reproductive system disorders. The company has market cap of $16.52 million. The Company’s product candidates include enclomiphene, which is a single isomer of clomiphene citrate, an orally active small molecule compound, and Proellex, which is an orally administered selective blocker of the progesterone receptor in women, for the treatment of uterine fibroids and endometriosis. It currently has negative earnings. Enclomiphene is for the treatment of secondary hypogonadism in overweight men wishing to restore normal testicular function.

Investors sentiment increased to 0.86 in 2017 Q2. Its up 0.03, from 0.83 in 2017Q1. It improved, as 4 investors sold BlackRock Enhanced Government Fund Inc shares while 3 reduced holdings. 2 funds opened positions while 4 raised stakes. 4.36 million shares or 3.36% more from 4.22 million shares in 2017Q1 were reported. Dynamic Solutions Lc has 0.1% invested in BlackRock Enhanced Government Fund Inc (NYSE:EGF). Moreover, Wolverine Asset Limited Liability Company has 0.01% invested in BlackRock Enhanced Government Fund Inc (NYSE:EGF) for 32,303 shares. National Bank & Trust Of America De reported 10,949 shares. Sit Inv Assocs, Minnesota-based fund reported 2.53 million shares. Icon Advisers stated it has 0.19% of its portfolio in BlackRock Enhanced Government Fund Inc (NYSE:EGF). Wells Fargo Co Mn holds 0% or 841,920 shares. Morgan Stanley holds 0% or 15,459 shares. 1607 Capital Limited Com accumulated 0.5% or 631,945 shares.

General American Investors Co Inc holds 0.02% of its portfolio in Repros Therapeutics Inc for 519,829 shares. Baldwin Brothers Inc Ma owns 1,750 shares or 0% of their US portfolio. Moreover, Bank Of America Corp De has 0% invested in the company for 56,087 shares. The Ontario – Canada-based Bank Of Montreal Can has invested 0% in the stock. Bank Of New York Mellon Corp, a New York-based fund reported 21,773 shares.

The stock increased 1.85% or $0.008 on November 14, reaching $0.418. About shares traded. Repros Therapeutics Inc (RPRX) has declined 73.82% since November 15, 2016 and is downtrending. It has underperformed by 90.52% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>